Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na_V1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

1 Correction to: Clinical Drug Investigation https://doi.org/10.1007/s40261-019-00807-3

The original version of this article unfortunately contained a mistake. A few entries were incorrect in Table 2.

The corrected Table 2 is given in the following page.

Table 2 Treatment-emergent AEs in ≥ 5% of GDC-0276-treated subjects: SD-PIC, SD-CD, and MD-PIC cohorts (all causalities)

The original article has been corrected.